Free CME from PeerView


Oncology CME

Robert Z. Orlowski, MD, PhD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Building Real-World Bridges Between Clinicians and Patients With Myeloma: Guidance on Innovative Antibody Options
Robert Z. Orlowski, MD, PhD / Peter Voorhees, MD
July 27, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
The Path for Better Outcomes in ALL: Integrating Modern Asparaginase Compounds Into the Care of Pediatric, AYA, and Adult Patients
Prof. Carmelo Rizzari
July 19, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
New Rules for BTK Inhibitors in CLL: Benchmarks for Evidence-Based Treatment Selection, Sequencing, and Safety Management
Prof. Dr. med. Stephan Stilgenbauer
July 15, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies: New Evidence on the Individualized Use of BTK Inhibitors in Relapsed/Refractory CLL/SLL and MCL
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD / Anthony R. Mato, MD, MSCE
July 15, 2022
Credits: 1.0 CME / MOC / NCPD
Penn State College of Medicine
Moving the Treatment of Advanced Gastroesophageal Cancers Forward: How Can We Maximize the Benefits of Novel Immunotherapy Approaches?
Yelena Y. Janjigian, MD
July 15, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Navigating From A to B and C in Multiple Myeloma: Delivering High-Quality Care With mAbs, BCMA ADCs, and Cellular Therapy
Sagar Lonial, MD, FACP
July 12, 2022
Credits: 1.0 CME
Penn State College of Medicine
Transforming Bladder Cancer Treatment: Essential Guidance for Urologists on Therapeutic Selection, Safety, and Sequencing Along the Disease Continuum
Ashish M. Kamat, MD, MBBS
July 08, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents
Elena Elez, MD, PhD
July 01, 2022
Credits: 0.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Applying Therapeutic Innovations Against ALL: From Updated Evidence to Everyday Practice
Luke Maese, DO
June 30, 2022
Credits: 1.75 CME / MOC
PVI, PeerView Institute for Medical Education
Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy From Advanced to Early Disease
David P. Carbone, MD, PhD
June 28, 2022
Credits: 0.75 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Candid Conversations and Clinical Consults in Community Context: Practical Guidance for Integrating TROP2-Targeting ADCs Into Patient-Centric Breast Cancer Clinical Care
Aditya Bardia, MD, MPH
June 23, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating the Shifting Treatment Paradigm in ER+/HER2- Breast Cancer: Harnessing Modern Treatment Options and the Expanding Evidence Base to Better Patient Care and Outcomes in Early and Advanced Disease
Aditya Bardia, MD, MPH
June 16, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Making Headway Towards Better Outcomes in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Multidisciplinary Tumor Board on Implementing Novel Locoregional and Systemic Approaches
Riad Salem, MD, MBA
June 16, 2022
Petros Grivas, MD, PhD
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Blazing the Trail Forward in the Therapeutic Management of Bladder Cancer: Expert Insights on Incorporating the Latest Evidence and Treatment Advancements Into Practice Across the Disease Continuum
Petros Grivas, MD, PhD
June 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Immunotherapy Has Arrived in Advanced BCC: Collaborative Strategies for Making the Most of Novel Immune-Based Treatment
Karl D. Lewis, MD
June 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Choosing Innovation With Immunotherapy in Melanoma: Guidance on Utilizing Immune-Based and Other Novel Options in Resectable and Unresectable Disease
Michael B. Atkins, MD
June 06, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Realizing the Potential of Novel Treatment Intensification Strategies for Metastatic Castration-Sensitive Prostate Cancer: The Experts’ Take on Key Clinical Evidence, Practical Considerations, and Best Practices for Individualized, Patient-Centered Care
Matthew R. Smith, MD, PhD
June 06, 2022
Jason Westin, MD, MS, FACP
Credits: 1.5 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Jason Westin, MD, MS, FACP
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
The "Myelennial" Generation: Managing the Boom of Innovative Therapy to Transform Myeloma Care and Enhance Patient Outcomes
Nina Shah, MD
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Setting the Course for the Optimal Management of HCC: Improving Patient Outcomes Through the Integration of Novel Therapeutic Approaches Across the Continuum of Care
Richard S. Finn, MD
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Find the Targets, Treat With Precision: Modern Principles and New Advances in Biomarker-Driven Lung Cancer Care
Stephen V. Liu, MD
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Established and Emerging Immune-Based Options Can Enhance Patient Care
Robert I. Haddad, MD
June 05, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Refining RCC Management Across the Disease Continuum: An Expert Clinical Consult on Leveraging New Evidence and Novel Therapeutic Strategies to Personalize Patient Care
Toni K. Choueiri, MD
June 04, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Rewriting the Treatment Script in CLL: Guidance on Integrating Modern Targeted and Next-Gen Options Into Patient Care
Anthony R. Mato, MD, MSCE
June 04, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
New Rules for Sequential Care in BRAF-Mutated Melanoma: Rethinking Upfront Selection and Sequencing of Immunotherapy and Targeted Agents in Metastatic Disease
Hussein A. Tawbi, MD, PhD
June 04, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
The Advantage of Innovation in AML: Guidance on Developing and Delivering Effective and Highly Personalized Care
Gail J. Roboz, MD
June 04, 2022
Jacob Sands, MD
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
Jacob Sands, MD
June 04, 2022
Zev A. Wainberg, MD
Credits: 0.75 CME / NCPD / CPE
PVI, PeerView Institute for Medical Education
Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients: A Strategy to Amplify Immune Response and Enhance or Restore Antitumor Activity
Zev A. Wainberg, MD / Shirish M. Gadgeel, MD
May 31, 2022
Jeanne M. Palmer, MD/Srdan Verstovsek, MD, PhD
Credits: 1.0 CME
The Medical College of Wisconsin
The Modern Management of Myelofibrosis: Practical Perspectives Surrounding the Use of JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting
Jeanne M. Palmer, MD / Srdan Verstovsek, MD,PhD
May 27, 2022
Nelson Chao, MD, MBA/Christine N. Duncan,MD
Credits: 1.0 CME
The Medical College of Wisconsin
Upgrading the VOD/SOS Management Tool Kit: Guidance for Effective Diagnostic Confirmation, Grading, and Treatment
Nelson Chao, MD, MBA / Christine N. Duncan, MD
May 26, 2022

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView